Back to TAKView Full LandscapeView full pipeline
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
7 competitors in Hidradenitis Suppurativa
INSMBrensocatib
Phase 3ABBVlutikizumab
Phase 3INCYPlacebo
Phase 2TXMDATI-450
Phase 2MRKtulisokibart
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
REPLAGALPhase 3
Fabry Disease
Alogliptin and pioglitazonePhase 3
Type 2 Diabetes Mellitus
IGSCPhase 3
Primary Immunodeficiency Disease
HYQVIAPhase 3
Primary Immunodeficiency Diseases (PID)
Azilsartan medoxomil, with or without chlorthalidone and other non-angiotensin II receptor blocker antihypertensive medicationsPhase 3
Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
